Cite
Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan
MLA
Yen-Yun Yang, et al. “Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan.” JAMA Network Open, vol. 4, no. 4, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....be554043f0d028422e4766650165ac01&authtype=sso&custid=ns315887.
APA
Yen-Yun Yang, K. Arnold Chan, Sung-Chao Chu, Ling-Yi Wang, & Yin Lo. (2021). Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan. JAMA Network Open, 4(4).
Chicago
Yen-Yun Yang, K. Arnold Chan, Sung-Chao Chu, Ling-Yi Wang, and Yin Lo. 2021. “Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan.” JAMA Network Open 4 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....be554043f0d028422e4766650165ac01&authtype=sso&custid=ns315887.